Analysts discuss Johnson & Johnson's outlook, highlighting MedTech challenges, litigation risks, pipeline opportunities, and mixed performance across segments.
Analyst Tim Anderson of Bank of America Securities reiterated a Hold rating on Johnson & Johnson (JNJ – Research Report), reducing the ...
Johnson & Johnson unveiled financial results that beat Wall Street expectations as the company braces for one of its ...
The interview was scheduled for Jan. 11. The Detroit Lions were deep into their postseason bye week and still awaiting their ...
Raymond James lowered the firm’s price target on Johnson & Johnson to $165 from $170 and keeps an Outperform rating on the shares.
Johnson & Johnson surpassed earnings expectations with strong sales, but it faces challenges ahead due to patent expirations.
New Chicago Bears head coach Ben Johnson has been named a finalist for AP Assistant Coach of the Year following his 2024 season as the Detroit Lions offensive coordinator.
16h
Johnson & Johnson (JNJ – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Lee ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback